Anthropic has launched Claude Science, an AI "workbench" aimed at scientists and researchers. According to Reuters, the company unveiled the tool on Tuesday, June 30, describing it as a system designed to help scientists streamline research, analyze data, and manage complex computing workflows.
The launch is being rolled out as a public beta, and Tech Times reports it is open to all paid subscribers. Rather than a chatbot in a browser, several outlets describe Claude Science as a research environment that lives inside the terminal — a nod to how much scientific work already happens in code and command lines. Anthropic claims the tool can do meaningful work by following concise, high-level instructions, according to the Indian Express.
Much of the coverage frames this as a commercial move as much as a scientific one. The Financial Times reports that Claude Science is part of Anthropic's push for pharmaceutical revenue, and outlets including pharmaphorum and medwatch position it squarely at pharma and life-sciences researchers — fields where wading through data and administrative overhead can slow discovery.
Anthropic is not alone in chasing this market. According to Tech Funding News, Google and OpenAI are already racing to match the offering, signaling that AI-for-science is becoming a key battleground among the major labs.
Why it matters: if these tools can genuinely cut the drudgery of data analysis and research administration, they could speed up work in drug development and other sciences — while giving AI companies a lucrative new industry to sell into.